ArticleBioprocess and biosystems engineering2021
Fabrication of silica on chitin in ambient conditions using silicatein fused with a chitin-binding domain.
Article in Bioprocess and biosystems engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 7 citations in OpenAlex.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High temperatures, harsh pH conditions, and toxic chemicals involved in the conventional synthesis and coating of silica limit the fabrication of new-generation hybrid materials immobilizing live cells and biomolecules such as enzymes and drugs. This hinders the application of inorganic-organic biohybrid materials in various fields, including bioelectronics, energy generation, and biomedicine. Silicatein, an enzyme found in siliceous sponges, catalyzes the polymerization of silica under mild conditions, that is, at room temperature and neutral pH. Silicatein was fused with a chitin-binding domain (ChBD) to selectively bind the fusion silicatein on the chitin material and with a small soluble tag called InakC, a hydrophilic protein from Pseudomonas syringae, to control the unfavorable aggregation of silicatein. The fusion silicatein was soluble in aqueous media and was successfully found to be adsorbed on the chitin material. The immobilized fusion silicatein acted as an interfacial catalyst to fabricate silica on chitin under ambient conditions. This technique can be used to fabricate inorganic-organic hybrid materials to immobilize biomolecules and can be applied to develop novel biocatalytic systems, biosensors, and tissue culture scaffolds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.